NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=124492&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=124491&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=124490&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=124489&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Warner Bros. Discovery, Inc. (NASDAQ:WBD) between February 23, 2024 and August 7, 2024, both dates inclusive (the "Class Period"), of the important January 24, 2025

GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia. The event was organized in collaboration with PT Bifarma Adiluhung (Bifarma), a pioneer in Indonesia's stem cell therapy sector, and showcased GC Cell's innovative cancer immunotherapy, Immuncell-LC. https://mma.prnewswire.com/media/2603430/image_5030355_16903221.jpg Insights into Immuncell-LC's mechanisms of

(NASDAQ:REGN), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. SO WHAT: If

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ:AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the "Class Period"), of the important February 3, 2025 lead

The Prime Minister, JustinTrudeau, today issued the following statement in tribute to the Honourable Nello Altomare: “Last week, Canada lost Nello Altomare, a dedicated public servant, community leader, and advocate for the people of Manitoba. “Throughout his life, Mr. Altomare was guided by a commitment to creating a better future. From his career as a

(NASDAQ:BOOM), SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) — Johnson Fistel, LLP announces that its Denver, Colorado office has filed a class action lawsuit on behalf of all purchasers of DMC Global Inc. (NASDAQ: BOOM) securities during the period between May 3, 2024 and November 4, 2024, both dates inclusive (the “Class Period”). The action